HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC lowered its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 8.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 951,235 shares of the company's stock after selling 86,545 shares during the period. Allspring Global Investments Holdings LLC owned approximately 1.10% of HealthEquity worth $92,079,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Louisiana State Employees Retirement System grew its position in shares of HealthEquity by 0.4% in the 4th quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company's stock worth $2,322,000 after buying an additional 100 shares during the last quarter. Peterson Wealth Services grew its position in HealthEquity by 5.1% during the 4th quarter. Peterson Wealth Services now owns 10,507 shares of the company's stock worth $1,008,000 after purchasing an additional 509 shares during the last quarter. Entropy Technologies LP purchased a new stake in HealthEquity during the 4th quarter worth approximately $224,000. Choreo LLC grew its position in HealthEquity by 7.2% during the 4th quarter. Choreo LLC now owns 22,879 shares of the company's stock worth $2,204,000 after purchasing an additional 1,533 shares during the last quarter. Finally, GDS Wealth Management grew its position in HealthEquity by 43.6% during the 4th quarter. GDS Wealth Management now owns 41,131 shares of the company's stock worth $3,947,000 after purchasing an additional 12,493 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company's stock.

Insiders Place Their Bets

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of the firm's stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the sale, the director now owns 19,061 shares of the company's stock, valued at $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now directly owns 78,219 shares of the company's stock, valued at $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 39,000 shares of company stock valued at $3,895,788 over the last quarter. 2.20% of the stock is owned by insiders.

HealthEquity Trading Down 1.1 %

HQY stock traded down $1.25 during trading on Friday, reaching $112.69. 483,217 shares of the stock were exchanged, compared to its average volume of 763,365. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The business has a 50 day moving average price of $102.14 and a 200-day moving average price of $90.94. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The firm has a market capitalization of $9.77 billion, a price-to-earnings ratio of 103.39, a P/E/G ratio of 1.61 and a beta of 0.55.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period in the previous year, the business earned $0.40 earnings per share. On average, research analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the stock. BTIG Research boosted their target price on shares of HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a research report on Thursday, November 14th. Bank of America lifted their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a research note on Wednesday, November 13th. Barrington Research lifted their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a research note on Monday, December 2nd. Royal Bank of Canada lifted their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the company an "outperform" rating in a research note on Tuesday, December 10th. Finally, Mizuho started coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They set an "outperform" rating and a $126.00 price objective for the company. One equities research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, HealthEquity currently has an average rating of "Moderate Buy" and an average price target of $110.71.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.